Benign lipomatous neoplasms, commonly referred to as lipomas, are the most common mesenchymal tumors in adults. These are benign growths composed of mature adipocytes (fat cells) typically encased within a thin, fibrous capsule. The ICD-10-CM code D17.3 specifically identifies lipomatous neoplasms located within the skin and subcutaneous tissues that are not classified under the more specific anatomical sites of the head, face, neck (D17.0), trunk (D17.1), or limbs (D17.2). These neoplasms are generally slow-growing, soft to the touch, and mobile under the skin. While most are asymptomatic and present as a cosmetic concern, they can occasionally cause localized pain or discomfort if they compress adjacent peripheral nerves or if they contain an extensive vascular component (angiolipoma). Histologically, these tumors are identical to normal white fat but are distinguished by their circumscribed nature and the presence of a delicate capsule.
Explicitly identify the anatomical site to the highest level of detail to avoid the use of unspecified codes. For D17.3, this should only be used if the site is documented but does not fall under head, face, neck, trunk, or limbs, such as the perineum or axilla, or if the clinician fails to specify the location.
Example: The patient presents with a 3.5 cm soft, mobile, non-tender subcutaneous mass located in the right inguinal region (groin). The mass has been stable for two years. Documentation of this specific site supports the use of D17.3 for an other site not classified elsewhere. Risk adjustment is maintained by noting the absence of rapid growth or systemic symptoms like weight loss, which rules out more severe neoplasms.
Billing Focus: Anatomical site specificity (other vs unspecified), size of the lesion, and laterality if applicable.
Document the depth of the lipoma, specifically noting involvement of the skin and subcutaneous tissue. This distinguishes the condition from deeper lipomas involving muscles or internal organs which require different ICD-10-CM codes in the D17.4 to D17.7 range.
Example: Physical exam reveals a 4 cm mass in the subcutaneous fat layer of the axilla, superficial to the fascia. No adherence to underlying muscular structures or deep tissue noted. This depth documentation justifies the D17.3 code over D17.5 or D17.7 codes. Billing is supported by confirming the superficial nature for the selection of the correct excision CPT code series.
Billing Focus: Tissue depth (subcutaneous vs deep/intramuscular), lesion size.
Specify the clinical indication for intervention such as pain, restriction of movement, or rapid enlargement. Documentation of symptoms is essential for proving the medical necessity of excision or biopsy to payers.
Example: The patient reports significant focal pain and irritation when wearing clothing over the 5 cm lipoma located in the axillary fold. The mass causes discomfort during shoulder abduction. Documenting functional impairment and pain justifies the medical necessity for excision (CPT 11406) rather than viewing the procedure as cosmetic. This supports the clinical severity for risk assessment.
Billing Focus: Medical necessity (pain, inflammation, functional impairment), ICD-10-CM code linkage.
Note the presence of multiple lipomas if applicable. If the patient has multiple lipomatosis, this should be documented as it may relate to underlying genetic syndromes or chronic management needs.
Example: Evaluation of a patient with multiple subcutaneous lipomas located in the groin and axillary regions bilaterally. Mass sizes range from 1 cm to 3 cm. History of multiple lipomatosis noted in family. Documenting the multiplicity supports higher complexity in management and potential for future procedures, impacting the longitudinal risk profile.
Billing Focus: Multiplicity of lesions, individual sizes for each excision performed.
Document the morphology and physical characteristics such as mobility, texture, and distinct borders. This reinforces the diagnosis of a benign lipomatous neoplasm over other dermatological conditions or malignant growths.
Example: Upon palpation, the 2 cm mass in the perineal skin is soft, encapsulated, and easily mobile under the skin surface. No overlying skin changes, ulceration, or lymphadenopathy noted. These benign characteristics support the D17.3 diagnosis and differentiate from malignant skin conditions that would require higher-intensity diagnostic paths.
Billing Focus: Physical characteristics, differential diagnosis support.
Appropriate for the initial evaluation of a symptomatic subcutaneous mass in a new patient.
Standard for follow-up evaluation of stable lipomas or pre-operative discussions.
Used when the lipoma is associated with complex comorbidities or requires extensive counseling on surgical risks.
Directly applies to excision of lipomas in other sites as classified under D17.3.
Used for excision of D17.3 lipomas within the specified size range.
Standard procedural code for mid-sized lipomas of the scalp or groin.
Used for more substantial lipomas found in D17.3 locations.
Relates to the removal of significant subcutaneous masses as classified by D17.3.
Used for the largest lipomas categorized under D17.3.
Used to confirm the benign lipomatous nature of a mass before full excision.
Used to evaluate the size, depth, and characteristics of a lipoma pre-operatively.
Frequently billed alongside excision codes when the depth of the lipoma requires multi-layered closure.